WA's flu season tipped to be second-worst in past decade as cases surge
But this time around, doctors really mean it.
We're only part-way through July and the rate of infections is already nearing full-year figures for previous years.
It's worrying experts, including the Australian Medical Association, whose president said West Australians should buckle up for a "difficult couple of weeks ahead".
Professor Yuben Moodley is a professor of respiratory medicine at the University of Western Australia, and said he expected this year to be the second-worst flu season in the last decade.
"The virus evolves and mutates every flu season and the aim of the virus is to avoid our immune response and to then infect cells more efficiently," he said.
"There's certain times and certain flu strains which are more effective in doing that than others.
That does not necessarily mean the flu is getting more severe, however.
"What happens though is that we have an increasing ageing population who are becoming more susceptible to the flu," Professor Moodley said.
"The flu in a young, healthy person is not going to have major consequences, but if you have much more aged people, it certainly will result in more hospitalisations than previously.
"So an increase in the ageing population will result in increased presentations to the doctor or to hospital."
It comes as national data showed a 50 per cent increase in hospital admissions over a fortnightly period due to the winter surge.
Those increased presentations have been blamed for increased pressure on hospitals, as shown by ambulance ramping figures.
Ambulances are considered "ramped" when they spend more than half-an-hour waiting outside a hospital to hand over a patient.
The average hours paramedics have spent ramped each day has been increasing significantly in WA since May, and is currently sitting just shy of records set at the peak of the pandemic.
Premier Roger Cook said it was not surprising the system would be under pressure at this time of year.
He also denied St John Ambulance struggling to meet its response time targets showed there needed to be extra capacity in the health system.
"We need to make sure that we deploy taxpayers' funds in an efficient manner, so you don't want to have too much extra capacity, you don't want to have too little extra capacity," he said.
"It's a matter of balance.
"But [the system's] performing well … and we'll continue to look at how we can improve hospital services."
Cook's view is in stark contrast to medical groups, including the Australian Medical Association, who suggest the state is at least 1,000 hospital beds short of being able to meet demand.
"While demand on our hospitals is high, it is being managed and pausing elective surgeries is not something that is being considered," Health Minister Meredith Hammat said during the week.
Compounding issues is that WA's flu season started earlier than usual.
"This year in particularly, possibly because of increased travel over the last six months, we have seen a worse flu season earlier than we expected," WA Health Director General Shirley Bowen told budget estimates earlier in July.
"Normally in Western Australia we might see a flu peak in July, August or September, often more in the August period.
"This year we saw new cases in January. That is sort of an overflow from the situation in the UK and Europe."
The solutions, of course, seem simple: vaccination and staying home when sick.
Actually getting people to do either of those things is much more difficult.
Western Australia's flu vaccine coverage was 25.4 per cent at the end of June — one per cent behind the national average and tied for second-last with Queensland.
Asked on Friday if she was happy with the uptake of the vaccine, Seniors Minister Simone McGurk would only the say the government was "sending a very, very strong message that we want people to be vaccinated" by making it free.
Professor Moodley thinks more needs to be done.
"I think it is important to address vaccine scepticism a little more strongly,"he said.
"Perhaps we can actually improve our outreach to people and to educate people better.
Preventative Health Minister Sabine Winton said earlier this month apathy was an issue.
"I am told the rate is about two per cent better than the case last year," she said.
"I do not want anyone to be complacent. We need to be doing much better than that to really have an even better impact on keeping people healthy and out of hospitals."
Like anything in health, that's likely to be expensive and take a long time.
It means at this stage, as cases continue to grow, there's little to do but stick to the basics and manage the pressures that result.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


SBS Australia
4 hours ago
- SBS Australia
Second case of rare mpox strain discovered in traveller
Listen to Australian and world news, and follow trending topics with SBS News Podcasts . "The patient has a close family, and that family are isolating at home. He was not contagious on the return journey to Australia from Africa, and those close contacts that he has been in contact including at the emergency ward and other locations are being contact traced right now and identified." That's Queensland's Health Minister Tim Nicholls, confirming a new strain of mpox virus has been detected in a man who's just returned to the south-east of the state from a trip to Africa. He says Mpox is a disease caused by the monkeypox virus. "Mpox is not easily spread. It is only spread or it can only spread through close or intimate contact. It is particularly spread by close sexual contact and particularly for gay men and people engaging with sex is the primary cause of the contagious spread." Dr Geoffrey Playford is the head of infectious diseases at the Princess Alexandra Hospital in Queensland. He says the rare Clade 1 strain of mpox has only been seen once before in Australia, also in a returned traveller. "Over the last year and a half in Queensland, we've had 135 cases in mpox clade 2 - this is the first case of clade 1 and the second time in Australia we've had clade 1. The other case was in New South Wales in May." Mr Nicholls says the public should NOT be concerned. "We think that there are 19 community contacts and 40 staff contacts that have been in contact with the patient. At the moment his symptoms are asymptomatic. They are not showing any signs of the clade 1 mpox, but they are isolating. The family involves children in high school, primary school and childcare centres and the high school, primary school and childcare centres either have been or are in the process of being identified." Dr Playford says authorities are not worried either. He says fortunately in this case the clinical presentation is relatively mild and there are no particular concerns for the patient's health. "And all of our efforts at the moment is to identify contacts using national guidelines to undertake quarantine where the very close contacts have been identified, again in line with the national guidelines." The close contacts will be offered a vaccine that is highly effective against mpox -either preventing or making the disease significantly milder and shorter. Mr Nicholls says over a year ago there were some restrictions on the availability of the vaccine. But now, Queensland has ample supplies - and the vaccine is provided free of charge through sexual health clinics and some GPs [[general practitioners]]. The Queensland government is advising anyone who suspects they may have the virus to seek medical advice from their local doctor, sexual health clinic or public health unit.


SBS Australia
6 hours ago
- SBS Australia
How some Aussies are tackling the 'massive hurdles' of ADHD diagnosis and treatment
When Zac Altman returned to Australia, he didn't expect that a frustrating journey trying to get rediagnosed with ADHD would propel him to start a business seeking to address the flaws of the system. Altman is the founder of Kantoko, a telehealth platform that offers ADHD assessment and care under a subscription model. After being diagnosed with ADHD while living in the United States, he returned home — and found he needed to start his diagnosis journey from scratch. "I was already diagnosed, already on the medication, had the documentation. I thought it was going to be pretty straightforward. And for me, it was a challenge," he told SBS News. "I don't think I ever would've made it through the process if I were starting in Australia from the get-go because of the massive hurdles and burdens required with getting through the process." Altman's struggles reflect a broader issue when it comes to the diagnosis and treatment of ADHD in Australia: despite rising awareness and demand, the system is still playing catch-up — and some states are lagging behind. Zac Altman says he would never have founded his ADHD telehealth business if he hadn't struggled with the diagnosis process himself. Source: Supplied A postcode lottery All states and territories have different laws governing how stimulant medications — commonly prescribed to treat ADHD — can be prescribed and dispensed. In some places, the process is more streamlined. In others, patients face stricter regulatory barriers — often accompanied by longer wait times and higher costs. Dr Roger Paterson, a psychiatrist based in Western Australia, said there was "always a postcode privilege for all levels of healthcare". "ADHD treatment is no different," he told SBS News. He said ADHD diagnosis and treatment rates have surged in Australia — but not uniformly. "We're still below the prevalence rates … but some states and territories have caught up quicker than others." Paterson told SBS News. Patterson said South Australia, Tasmania, Victoria and the Northern Territory remain the slowest to catch up, while Western Australia — which once lagged behind — has now reached similar levels to Queensland. "No-one really knows why [some states lag], beyond the NT not having many specialists — paediatricians or psychiatrists. But they are all gradually catching up to the ADHD prevalence rates." Prevalence refers to the proportion of a population that is affected by ADHD. While there are no Australian adult prevalence studies of ADHD using the current DSM-5 diagnostic criteria, some studies have indicated the prevalence of ADHD in Australia is likely to be similar to that found internationally — between 2 and 6 per cent of the population, according to the Australasian ADHD Professionals Association. Rates of prescribing vary across states and territories, reflecting the different jurisdictional laws about stimulant prescribing. Source: SBS News Additionally, the federal government's Drug Utilisation Sub Committee September 2023 report found differences in the rates of prescribing across states and territories, which the report says reflects different laws across jurisdictions. Adult rates of prescribing were significantly higher in Western Australia and the ACT compared to the other states and the Northern Territory. The federal Senate inquiry into ADHD, handed down in November 2023, examined the barriers to consistent, timely and best-practice assessment of ADHD. It heard those living in regional and rural areas were subject to even more barriers to care, with reduced access to specialists, longer wait times and higher costs. Altman said the differences were most pronounced in Kantoko clients moving interstate who had to navigate different jurisdictional regulations, sometimes requiring them to find an entirely new specialist. "It seems somewhat unreasonable to expect every psychiatrist to know every quirk across the country ... which is why I would argue we should have some sort of national standard around this stuff," he said. A patchwork system with no national rules Altman said going through the assessment process in Australia can feel like "a roll of the dice" due to a lack of national rules. He said he paid about $1,500 out of pocket to be rediagnosed in his first year back in Australia — including an upfront $1,000 fee to secure a psychiatrist appointment in NSW. He said he was fortunate to have leftover medication from the US to tide him over in the months he waited, but he knows others aren't so lucky. "It's the luck of the draw," he said. The inquiry heard that of those who did have positive experiences of ADHD assessment and diagnosis, "many attributed their experience to luck" or to doctors and psychiatrists who helped them access services. There is no national framework for ADHD, despite it being a key recommendation in the inquiry. The inquiry heard wait times were found to be "significant", typically between six and 18 months for an initial appointment, while the Australian Association of Psychologists Inc said the number of mental health professionals has not kept up with the demand for services. The public system rarely treats the condition except in children, pushing adults seeking a diagnosis to the private sector. As specialists set their own fees with no cap, people can be subject to high fees. The ADHD Foundation said it had observed some professionals charge up to $5,000 for assessments. 'Kantoko wouldn't exist if Australia nailed it' In response, ADHD telehealth services like Kantoko have cropped up. Operating completely online, these clinics promise shorter wait times — but sometimes at a greater cost. Kantoko operates under a subscription model. Medicare does not cover any fees. In exchange, patients are promised an ADHD assessment by a qualified psychiatrist, follow-up appointments with mental health doctors and prescription renewals. "Kantoko wouldn't exist if Australia had nailed it," Altman said. "I wouldn't have gotten so frustrated that I started this business and embarked on this journey if it were easy-to-access and affordable." But the Senate inquiry heard concerns about the growing telehealth service model, saying that while it was helpful for those in regional areas, it has also driven up risks associated with "inadequate assessment and misdiagnosis", according to the Australian College of Mental Health Nurses. The Canberra and Queanbeyan ADHD Support Group, a volunteer-run local group, said the clinics offered "exceedingly high fees delivering a quick turnaround" with concerns of "price gouging". The GP debate: solving shortages or lowering the bar? As the system plays catch-up, a key recommendation from the inquiry was the development of uniform and nationally consistent ADHD prescribing rules — the only recommendation of the 15 that the government accepted in full. But the government said the establishment of prescribing arrangements, including increased GP involvement, was a matter for state and territory governments. NSW, ACT, SA and WA have committed to reforms that will allow specially trained GPs to prescribe ADHD medication independently from 2025 and 2026. They'll join jurisdictions like Queensland, where GPs have been able to prescribe certain ADHD medications for children without prior approval since 2017. While some say it could ease bottlenecks and encourage holistic care, others warn it risks lowering the standards of care. Paterson said the current model is for specialists to handle diagnosis and stabilisation, before shifting to a shared care arrangement with GPs — known as co-prescribing. He's sceptical of political moves to shift ADHD treatment onto GPs in an effort to play catch-up. "Some GPs have pushed for taking on initial, independent assessment and prescribing, and politicians push this along as a popular way of reducing waiting lists," Paterson said. "This creates a tension between reducing waitlists with more GP involvement on the one hand, but on the other hand, accepting that GP ADHD management may not have the nuance of specialist management." There are concerns that relaxing GP restrictions could open the door to so-called 'dexy clinics' — where stimulant medications such as dexamphetamines might be handed out too freely, similar to concerns seen with medicinal cannabis. "There would be less concern about lower GP numbers who are highly trained, and more concern about higher GP numbers who are less trained," Paterson said. "The worst case scenario is that stimulant medication becomes as accessible as cannabis from the medicinal cannabis clinics." But Dr Alison Poulton, a senior lecturer in paediatrics at The University of Sydney and member of ADHD Australia's advisory board, pushed back against 'dexy clinic' fears, saying that ongoing relationships between GPs and patients would reduce risk and encourage more holistic care. She criticised current restrictions requiring specialist endorsement and fixed dosage limits, arguing they undermine both patient autonomy and the ability of GPs to tailor care. "It makes complete nonsense of patient autonomy," she said. "Decisions should be made between the GP and patient, not based on a letter written five years ago." Poulton emphasised that GPs, who often have a long-term understanding of their patients, are well placed to make prescribing decisions that reflect changing needs, leading to better functional outcomes. "I think the GPs are going to do a much better job if they know it's up to them to make these prescribing decisions rather than to have to consult the specialist."

News.com.au
7 hours ago
- News.com.au
Aussie supplement company Blackmores facing potential class action over allegedly ‘toxic' levels of B6 in products
Australian supplement giant Blackmores is facing potential class-action lawsuit, over claims that excessive levels of vitamin B6 in some of the company's over-the-counter products have led to serious health complications. Dominic Noonan-O'Keeffe began taking Blackmores supplements in May 2023 to support his health, ahead of the birth of his first child. Unaware the magnesium product contained potentially 'toxic' levels of vitamin B6, he claims he soon developed severe symptoms – including fatigue, headaches, muscle spasms, heart palpitations, and loss of sensation, according to Polaris lawyers. Doctors later diagnosed him with neuropathy linked to excessive B6 intake. Despite stopping in early 2024, Mr Noonan-O'Keeffe claims he continues to suffer daily from nerve pain and other symptoms. Polaris Lawyers – who are representing Mr Noonan-O'Keeffe, the lead plaintiff in the potential class-action – allege they later discovered the magnesium product contained about 29 times the recommended daily intake of vitamin B6. Polaris Lawyers is now investigating a proposed class action against Blackmores for the excessive B6 levels in their vitamin supplements. 'It's alarming to walk down the vitamin aisle of any chemist in Australia and see vitamin supplements containing levels of B6 which are far and above the recommended daily intake,' Polaris Lawyers Founder and Principal Nick Mann said. 'What happened to Dominic is tragic, but he is not alone – we are aware of reports that excessive levels of B6 in over-the-counter supplements may have caused lasting injuries to hundreds of Australians. 'Polaris Lawyers is currently investigating a class action on behalf of anyone who has suffered injuries as a result of excessive levels of B6 as a result of taking Blackmores vitamin supplements.' In an interim decision report released in June, the TGA acknowledged no clear consensus on a safe vitamin B6 level that fully prevents peripheral neuropathy. The decision proposed rescheduling products containing over 50mg per day as 'Pharmacist Only Medicines.' A Blackmores spokesperson said they were aware of the TGA's proposed changes. 'At Blackmores, we are committed to the highest standards of product quality and consumer safety. All our products, including those containing Vitamin B6, are developed in strict accordance with the regulatory requirements of the Therapeutic Goods Administration (TGA),' the spokesperson said. 'This includes compliance with maximum permitted daily doses and the inclusion of mandated warning statements. 'We acknowledge the interim decision issued by the TGA and we will ensure full compliance with its final determination.'